Multiples studies in humans have described the regulatory molecular mechanisms controlling CRP gene expression in liver, as well as identified mutations associated with CRP blood levels and cardiovascular disease risk (6, 49, 50). This evidence concerns the gene CRP and cardiovascular disorder.